PALBOCICLIB

95562 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking PALBOCICLIB:

# Side effect Count
0 FATIGUE 15790
1 WHITE BLOOD CELL COUNT DECREASED 11486
2 NEOPLASM PROGRESSION 10612
3 NAUSEA 8591
4 DEATH 8004
5 NEUTROPENIA 6803
6 ALOPECIA 6384
7 DIARRHOEA 6015
8 ASTHENIA 3823
9 OFF LABEL USE 3677
See all common reactions for PALBOCICLIB

PALBOCICLIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARBOHYDRATE ANTIGEN 27.29 INCREASED 57 0.3800
1 BODY SURFACE AREA INCREASED 41 0.3178
2 PIK3CA-ACTIVATED MUTATION 102 0.3072
3 NEOPLASM PROGRESSION 10612 0.3048
4 CARBOHYDRATE ANTIGEN 15-3 INCREASED 177 0.2326
5 TUMOUR MARKER ABNORMAL 62 0.1873
6 TUMOUR MARKER INCREASED 876 0.1824
7 PSEUDOCIRRHOSIS 47 0.1416
8 METASTASES TO EYE 30 0.1370
9 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 42 0.1265
See all enriched reactions for PALBOCICLIB